Background illustration for clinical trials search

Paid Clinical Trials Louisville

Discover 495 paid clinical trials in Louisville, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

for
Paroxysmal Atrial Fibrillation
Location: Louisville KY, Cincinnati OH, Ypsilanti MI, Lansing MI,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

Sex: All

Age: 18+

Code: NCT06324201

Recruiting

Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps

for
Chronic Rhinosinusitis Without Nasal Polyps
Location: Louisville KY, Springfield IL, Columbia MO,
Sponsor: Optinose US Inc.

Sex: All

Age: 12 - 17

Code: NCT06850805

Phase3, Recruiting

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

for
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation,
Location: Louisville KY, Saint Matthews KY, Cincinnati OH,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

Sex: All

Age: 18+

Code: NCT04088071

Recruiting

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

for
Heart Failure
Location: Louisville KY, Indianapolis IN, Richmond IN, Marion OH,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06424288

Phase3, Recruiting

Left vs Left Randomized Clinical Trial

for
Heart Failure, Heart Failure With Reduced Ejection Fraction,
Location: Louisville KY, Cincinnati OH, Indianapolis IN,
Sponsor: Baylor College of Medicine

Sex: All

Age: 18+

Code: NCT05650658

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Pan-tumor MRD Study

for
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer,
Location: Louisville KY, Elizabethtown KY, Lexington KY,
Sponsor: Paradigm Health

Sex: All

Age: 18+

Code: NCT06605404

Recruiting

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women

for
Coronary Artery Disease
Location: Louisville KY, Lexington KY, Carmel IN, Nashville TN,
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18+

Code: NCT06399692

Phase3, Recruiting

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

for
Heart Failure - NYHA II - IV
Location: Louisville KY, Indianapolis IN, Nashville TN,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT07069738

Recruiting

Genetic and Environmental Risk Factors for Hemorrhagic Stroke

for
Stroke
Location: Louisville KY, Cincinnati OH, Durham NC, Baltimore MD,
Sponsor: State University of New York at Buffalo

Sex: All

Age: 18+

Code: NCT00682695

Recruiting

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

for
Coronary Artery Disease
Location: Louisville KY, Lexington KY, Carmel IN, Nashville TN,
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18+

Code: NCT06399705

Phase3, Recruiting

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

for
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Location: New Albany IN, Lexington KY, Miamisburg OH, Columbus OH,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT06072482

Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Louisville KY, Nashville TN, Columbus OH, Chicago IL,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase1, Recruiting

A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL

for
Indolent B-Cell Non-Hodgkin Lymphoma
Location: Louisville KY
Sponsor: BioInvent International AB

Sex: All

Age: 18+

Code: NCT03571568

Phase1, Phase2, Recruiting

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

for
Multiple Myeloma (MM)
Location: Louisville KY, Atlanta GA, Grand Rapids MI, Durham NC,
Sponsor: C4 Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07280013

Phase1, Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

for
Systemic Lupus Erythematosus (With and Without Nephritis),
Location: Louisville KY, Chicago IL, Greenville SC, Charlotte NC,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07085104

Phase1, Recruiting

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Louisville KY, Hilliard OH, Chicago IL, Detroit MI,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06787612

Phase2, Recruiting

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Louisville KY, Cincinnati OH, Nashville TN, Columbus OH,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06297226

Phase2, Recruiting

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Louisville KY, Lexington KY, Cincinnati OH,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07213804

Phase3, Recruiting

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

for
Lymphoma, Large B-Cell, Diffuse
Location: Louisville KY, Elizabethtown KY, Lexington KY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06890884

Phase2, Recruiting

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for
Diffuse Large B-Cell Lymphoma
Location: Louisville KY, Lexington KY, Owensboro KY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06717347

Phase3, Recruiting